Publication:
The role of hypoxia in pancreatic cancer: a potential therapeutic target?

dc.contributor.coauthorKleeff, Jorg
dc.contributor.departmentKUTTAM (Koç University Research Center for Translational Medicine)
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorErkan, Murat Mert
dc.contributor.kuauthorKurtoğlu, Metin
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.contributor.schoolcollegeinstituteResearch Center
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T22:57:05Z
dc.date.issued2016
dc.description.abstractOne of the key factors that correlates with poor survival of patients with pancreatic cancer is the extent of hypoxic areas within the tumor tissue. The adaptation of pancreatic cancer cells to limited oxygen delivery promotes the induction of an invasive and treatment-resistant phenotype, triggering metastases at an early stage of tumor development, which resist in most cases adjuvant therapies following tumor resection. In this article, the authors summarize the evidence demonstrating the significance of hypoxia in pancreatic cancer pathogenesis and discuss the possible hypoxia-induced mechanisms underlying its aggressive nature. We then conclude with promising strategies that target hypoxia-adapted pancreatic cancer cells.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue3
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume10
dc.identifier.doi10.1586/17474124.2016.1117386
dc.identifier.eissn1747-4132
dc.identifier.issn1747-4124
dc.identifier.scopus2-s2.0-84959141784
dc.identifier.urihttps://doi.org/10.1586/17474124.2016.1117386
dc.identifier.urihttps://hdl.handle.net/20.500.14288/7479
dc.identifier.wos370754900004
dc.keywordsPegph20
dc.keywordsPancreatic cancer
dc.keywordsDesmoplasia
dc.keywordsMetabolism
dc.keywordsHypoxia
dc.keywordsCancer stem cell
dc.keywordsEpithelial-to-mesenchymal transition
dc.keywordsTh-302 epithelial-mesenchymal transition
dc.keywordsReductive glutamine-metabolism
dc.keywordsMtor inhibitor everolimus
dc.keywordsInducible factor-1-Alpha
dc.keywordsCell-death
dc.keywordsStellate cells
dc.keywordsSuperoxide-dismutase
dc.keywordsAlpha-ketoglutarate
dc.keywordsPrognostic marker
dc.keywordsUp-regulation
dc.language.isoeng
dc.publisherTaylor and Francis Ltd
dc.relation.ispartofExpert Review of Gastroenterology & Hepatology
dc.subjectGastroenterology
dc.subjectHepatology
dc.titleThe role of hypoxia in pancreatic cancer: a potential therapeutic target?
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorErkan, Murat Mert
local.contributor.kuauthorKurtoğlu, Metin
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit1Research Center
local.publication.orgunit1KUH (KOÇ UNIVERSITY HOSPITAL)
local.publication.orgunit2KUTTAM (Koç University Research Center for Translational Medicine)
local.publication.orgunit2KUH (Koç University Hospital)
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublication91bbe15d-017f-446b-b102-ce755523d939
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscovery91bbe15d-017f-446b-b102-ce755523d939
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files